TCIM
BLUE

TIAA CREF Investment Management’s bluebird bio BLUE Stock Holding History

TIAA CREF Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$29.3M Sell
14,377
-3,303
-19% -$5.82M 0.02% 559
2018
Q4 		$22.7M Sell
17,680
-1,544
-8% -$2.37M 0.02% 607
2018
Q3 		$36.4M Sell
19,224
-186
-1% -$384K 0.02% 532
2018
Q2 		$39.5M Buy
19,410
+1,405
+8% +$3.2M 0.03% 507
2018
Q1 		$39.8M Sell
18,005
-586
-3% -$1.49M 0.03% 513
2017
Q4 		$42.9M Buy
18,591
+855
+5% +$1.74M 0.03% 493
2017
Q3 		$31.6M Buy
17,736
+1,044
+6% +$1.46M 0.02% 585
2017
Q2 		$22.7M Buy
16,692
+6,144
+58% +$7.41M 0.02% 697
2017
Q1 		$12.4M Sell
10,548
-880
-8% -$898K 0.01% 983
2016
Q4 		$9.13M Buy
11,428
+1,588
+16% +$1.26M 0.01% 1185
2016
Q3 		$8.64K Sell
9,840
-1,834
-16% -$1.33M 0.01% 1220
2016
Q2 		$6.55M Sell
11,674
-14,530
-55% -$8.23M 0.01% 1350
2016
Q1 		$14.4M Buy
26,204
+15,006
+134% +$9.22M 0.01% 869
2015
Q4 		$9.32M Sell
11,198
-239
-2% -$239K 0.01% 1112
2015
Q3 		$12.7M Sell
11,437
-85
-0.7% -$155K 0.01% 921
2015
Q2 		$25.1M Sell
11,522
-593
-5% -$1.21M 0.02% 712
2015
Q1 		$19M Buy
12,115
+2,890
+31% +$3.81M 0.01% 805
2014
Q4 		$11M Sell
9,225
-98
-1% -$65.5K 0.01% 1056
2014
Q3 		$4.33M Buy
9,323
+1,248
+15% +$576K ﹤0.01% 1721
2014
Q2 		$4.03M Buy
8,075
+5,596
+226% +$1.79M ﹤0.01% 1840
2014
Q1 		$730K Buy
2,479
+642
+35% +$195K ﹤0.01% 2807
2013
Q4 		$499K Buy
1,837
+563
+44% +$157K ﹤0.01% 2959
2013
Q3 		$445K Buy
+1,274
New +$473K ﹤0.01% 2960

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's BLUE Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its bluebird bio (BLUE) stake by 19% in Q1 2019, selling an estimated $5.82M and leaving 14,377 shares worth $29.3M. The position accounts for 0.02% of the portfolio, ranked #559.

TIAA CREF Investment Management first reported a position in BLUE in Q3 2013 and has held it in 23 quarters since. The position peaked at $42.9M in Q4 2017. 288 funds tracked by Wall St. Rank hold BLUE as of Q1 2019.

  • TIAA CREF Investment Management held 14,377 shares of bluebird bio worth $29.3M as of Q1 2019.
  • TIAA CREF Investment Management sold 3,303 bluebird bio shares in Q1 2019, an estimated $5.82M.
  • bluebird bio made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #559 holding.
  • TIAA CREF Investment Management first reported a position in bluebird bio in Q3 2013 and has held it in 23 quarters since.
  • TIAA CREF Investment Management's bluebird bio position peaked at $42.9M in Q4 2017.
  • 288 funds tracked by Wall St. Rank held bluebird bio as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.